PROJECT 8P INTERVIEW ON OVID THERAPEUTICS’S BOLD MEDICINE PODCAST

Project 8p Founder & President, Bina Shah, was recently interviewed on the Ovid Therapeutics’s Bold Medicine Podcast with Amit Rakhit,MD, MBA, Chief Medical Officer of Ovid Therapetuics, and Luke Rosen, Founder of Kif1a.org.

Ovid Therapeutics is a company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Hosted by Amit Rakhit, MD, MBA, this is our podcast. This is Bold Medicine.

“What’s it going to take? it all comes down to WHO can we get involved. We have to keep reminding ourselves it’s not about problems, it’s about solutions.”

Chromosome 8p is a rare genetic condition with approximately 350 patients identified around the world and counting. In this week’s episode Amit sits down with Bina Shah, Founder of Project 8p, innovator and leader in the rare disease community.

In 2018, Bina founded Project 8p to accelerate research with the goal of treatment for chromosome 8p heroes like her daughter Karina. Her family resides in New York City where Bina earned her B.S. in Finance & Marketing from NYU Stern Business School as well as her M.B.A. from Columbia University. She has over 15 years of experience in finance in the areas of mergers and acquisitions, private and public equity investing, real estate development, and property management.

Listen to the Podcast Now

APPLE PODCASTS: BOLD MEDICINE

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.
  • Lead with knowledge from patients. Currently, there is no cure for 8p disorders, nor is there a standard course of treatment.

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Raise transformative funding for pioneering scientific research into treatments for a complex, rare disease involving 250+ affected genes on the short arm of the 8 th chromosome (8p). Rearrangements of these genes causes significant abnormalities to the entire neurological system, thus all organs and functions of the body– with variance in cognitive functions, gross motor skills, social development and other challenges during infancy, and throughout life;
  • Empower a unified community of 8p patients and their families so they can have meaningful lives today; and
  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.